Life Science Industry Updates


  • All
  • Manufacturing
  • Marketing
  • Biotech
  • All

    Biopharma Update on the Novel Coronavirus: September 18

    Biopharma Update on the Novel Coronavirus: September 18

    Share with a colleague. Biospace

    Research Roundup: Social Distancing and COVID-19 and More

    Share with your team. Biospace

    Chiasma’s Octreotide Capsules Could Be Answer to Acromegaly Treatment Burdens

    You heard it from SOURCE EXPLORER. Biospace

    BioNTech to buy Novartis manufacturing plant to bolster vaccine supply

    Did you know about this? BioPharma Dive

    Moderna and Pfizer, having shown speed with coronavirus vaccines, see opportunity in seasonal flu

    Passing this around on e-mail today. BioPharma Dive

    Lilly says it's 'extremely well-positioned' to supply Olumiant if granted an emergency authorization in COVID-19

    All the latest. Fierce Pharma

    ESMO: Pfizer's Ibrance flop in early breast cancer shouldn't hurt metastatic sales, exec says

    Life Science news you need to know. Fierce Pharma

    ESMO: Chi-Med's surufatinib gears up to challenge Novartis, Pfizer with placebo-topping phase 3

    Stay connected to what’s happening in Life Sciences. Fierce Biotech

    Sponsored Ad

    Featured

    ESMO: Merck and AstraZeneca's 5-Year Lynparza Data in Ovarian Cancer and More

    ESMO: Merck and AstraZeneca's 5-Year Lynparza Data in Ovarian Cancer and More

    Sit down for this one. Biospace

    Roche Launches New COVID-19 Antibody Test to Support Vaccine Testing

    Worth the read. Biospace

    BioSpace Movers & Shakers, Sept. 18

    So relevant. Biospace

    Sponsored Ad

    Seattle Genetics stays step ahead of rivals with bladder cancer data

    What do you think? BioPharma Dive

    In unexpected finding, Roche claims arthritis drug may have role in treating COVID-19

    You’ll want to read this between meetings. BioPharma Dive

    Sanofi, GlaxoSmithKline score EU supply pact for 300M coronavirus shots

    This is what’s on our minds. Fierce Pharma

    ESMO: Merck's Keytruda matches Opdivo on key survival metric for post-surgery melanoma

    Explore recent news. Fierce Pharma

    ESMO: Novartis posts data from failed spartalizumab phase 3, reaffirms commitment to PD-1 combos

    Who do you know who’d find this relevant? Fierce Biotech

    SOURCE EXPLORER Updates

    The Most Promising COVID-19 Vaccines in Development

    The Most Promising COVID-19 Vaccines in Development

    Sponsored Ad

    7 Key Life Science Marketing Trends

    7 Key Life Science Marketing Trends

    “SYMPTOMSPLAINING”

    “SYMPTOMSPLAINING”

    Competition vs. Collaboration in Life Sciences in a Post-COVID World

    Competition vs. Collaboration in Life Sciences in a Post-COVID World

    Life Science Processes – Going Beyond Meetings

    Life Science Processes – Going Beyond Meetings

    View all Updates